HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
1 clinical trials · Condition
◉ Watch HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer (NCT06146114) | Qilu Hospital of Shandong University | 2023-07-01 |
Track HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.